4//SEC Filing
Halladay Benjamin 4
Accession 0001628280-23-007968
CIK 0001434868other
Filed
Mar 14, 8:00 PM ET
Accepted
Mar 15, 9:21 AM ET
Size
11.2 KB
Accession
0001628280-23-007968
Insider Transaction Report
Form 4
Halladay Benjamin
Chief Financial Officer
Transactions
- Award
Common Stock
2023-03-14+9,200→ 73,936 total - Award
Stock Option (right to buy)
2023-03-14+39,000→ 39,000 totalExercise: $4.02Exp: 2033-03-14→ Common Stock (39,000 underlying)
Footnotes (3)
- [F1]Such award will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
- [F2]Consists of 73,936 shares of common stock held, including 2,306 shares recently acquired in Esperion's Employee Stock Purchase Plan.
- [F3]Such options will vest over a four (4) year period in equal quarterly installments, the first of which shall be on June 15, 2023, subject to continued service.
Issuer
Esperion Therapeutics, Inc.
CIK 0001434868
Entity typeother
Related Parties
1- filerCIK 0001953943
Filing Metadata
- Form type
- 4
- Filed
- Mar 14, 8:00 PM ET
- Accepted
- Mar 15, 9:21 AM ET
- Size
- 11.2 KB